Drug-induced pancreatitis: Incidence, management and prevention

Drug Safety

Volumn 31, Issue 10, 2008, Pages 823-837

  Balani, Anil R ^a,b   Grendell, James H ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

ACE inhibitors, adverse reactions; Aminosalicylic acids, adverse reactions; Angiotensin receptor antagonists, adverse reactions; Azathioprine, adverse reactions; Codeine, adverse reactions; Estradiol congeners, adverse reactions

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; CHLOROTHIAZIDE; CHLORTALIDONE; CODEINE; CORTICOSTEROID; CORTISONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ESTROGEN; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISONIAZID; LISINOPRIL; LOSARTAN; MEGLUMINE ANTIMONATE; MERCAPTOPURINE; MESALAZINE; METHYLDOPA; METRONIDAZOLE; OMEPRAZOLE; RAMIPRIL; SIMVASTATIN; STIBOGLUCONATE SODIUM; SULINDAC; TETRACYCLINE; UNINDEXED DRUG; VALPROIC ACID;

ACUTE PANCREATITIS; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ENTERITIS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OXYGEN SATURATION; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW;

ACUTE DISEASE; DRUG TOXICITY; HUMANS; INCIDENCE; PANCREATITIS; PHARMACEUTICAL PREPARATIONS;

EID: 50649112783     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200831100-00002     Document Type: Review

References (239)

1. Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006; 101: 2379-400
2. Pandol SJ, Saluja AK, Imrie CW. Acute pancreatitis: bench to the bedside. Gastroenterology 2007; 132: 1127-51
3. Johnston DH, Cornish A. Acute pancreatitis in patients receiving chlorothiazide. JAMA 1959; 170: 2054-6
4. Zion MM, Goldberg B, Suzman MM. Corticotrophin and cortisone in the treatment of scleroderma [letter]. Q J Med 1955; 24: 215
5. Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther 2003; 17: 887-93
6. Mallory A, Kern F. Drug induced pancreatitis: a critical review. Gastroenterology 1980; 78: 813-20
7. Underwood TW, Frye CB. Drug-induced pancreatitis. Clin Pharm 1993; 12: 440-8
8. McArthur KE. Drug-induced pancreatitis. Aliment Pharmacol Ther 1996; 10: 23-38
9. Wilmink T, Frick TW. Drug-induced pancreatitis. Drug Saf 1996; 14: 406-23
10. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an up-date. J Clin Gastroenterol 2005; 39: 709-16
11. Badalov N, Baradarian R, Iswara K, et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol 2007; 5: 648-61
12. Dhir R, Brown DK, Olden KW. Drug-induced pancreatitis: a practical review. Drugs Today 2007; 43: 499-07
13. Maringhini A, Termini A, Patti R, et al. Enalapril-associated pancreatitis: recurrence after rechallenge. Am J Gastroenterol 1997; 92: 166-7
14. Carnovale A, Esposito P, Bassano P, et al. Enalapril-induced acute recurrent pancreatitis. Dig Liver Dis 2003; 35: 55-7
15. Gershon T, Olshaker JS. Acute pancreatitis following lisinopril rechallenge. Am J Emerg Med 1998; 16: 523-4
16. Kanbay M, Selcuk H, Yilmaz U. Recurrent acute pancreatitis secondary to lisinopril. South Med J 2006; 99: 1388-9
17. Kanbay M, Korkmaz M, Yilmaz U, et al. Acute pancreatitis due to ramipril therapy. Postgrad Med J 2004; 80: 617-8
18. Bosch X. Losartan-induced acute pancreatitis. Ann Intern Med 1997; 127: 1043-4
19. Birck R, Keim V, Fiedler F, et al. Pancreatitis after losartan [letter]. Lancet 1998; 351: 1178
20. Van der Heide H, Ten Haaft MA, Stricker BH. Pancreatitis caused by methyldopa. BMJ (Clin Res Ed) 1981; 282: 1930-1
21. Rominger JM. Gutierrez JG. Curtis D, et al. Methyldopa-induced pancreatitis. Am J Dig Dis 1978; 23: 756-8
22. Jones PE. Oelbaum MH. Furosemide induced pancreatitis. BMJ 1975; 1: 133-4
23. Juang P, Page RL, Zolty R. Probable loop diuretic-induced pancreatitis in a sulfonamide-allergic patient. Ann Pharmacother 2006; 40: 128-34
24. Cornish AL, McClellan JT, Johnston DH. Effects of chlorothiazide on the pancreas. N Engl J Med 1961; 265: 673-5
25. Rion RJ. Recurrent pancreatitis after treatment with hydrochlorothiazide. J Am Board Fam Pract 1994; 7: 74-6
26. Bosch X, Bernadich O. Acute pancreatitis during treatment with amiodarone [letter]. Lancet 1997; 350: 1300
27. Ceciliato R, Pezzilli R, Corinaldesi R, et al. Acute pancreatitis due to simvastatin therapy: increased severity after rechallenge. Dig Liver Dis 2004; 36: 639-40
28. Johnson JL, Loomis IB. A case of simvastatin-associated pancreatitis and review of statin-associated pancreatitis. Pharmacotherapy 2006; 26: 414-22
29. Anagnostopoulos GK, Tsiakos S, Margantinis G, et al. Acute pancreatitis due to pravastatin therapy. JOP 2003; 4: 129-32
30. Tysk C, Al-Eryani AY, Shawabkeh AA. Acute pancreatitis induced by fluvastatin therapy. J Clin Gastroenterol 2002; 35: 406-8
31. Gang N, Langevitz P, Livneh A. Relapsing acute pancreatitis induced by re-exposure to the cholesterol lowering agent bezafibrate. Am J Gastroenterol 1999; 94: 3626-8
32. Elmore MF, Rogge JD. Tetracycline-induced pancreatitis. Gastroenterology 1981; 81: 1134-6
33. Torosis J, Vender R. Tetracycline-induced acute pancreatitis. J Clin Gastroenterol 1987; 9: 580-1
34. Sanford KA, Mayle JE, Dean HA, et al. Metronidazole-associated pancreatitis. Ann Intern Med 1988; 109: 756-7
35. Celifarco A, Warschauer C, Burakoff R. Metronidazole induced pancreatitis. Am J Gastroenterol 1989; 84: 958-63
36. Jha SH, Reddy JA, Dave JK. Dapsone-induced acute pancreatitis. Ann Pharmacother 2003; 37: 1438-40
37. Antonow DR. Acute pancreatitis associated with trimethoprim- sulfamethoxazole. Ann Intern Med 1986; 104: 363-5
38. Versleijen MW, Naber AH, Riksen NP, et al. Recurrent pancreatitis after trimethoprim-sulfamethoxazole rechallenge. Neth J Med 2005; 63: 275-7
39. Nelis GF. Nitrofurantoin-induced pancreatitis: report of a case. Gastroenterology 1983; 84: 1032-4
40. Christophe JL. Pancreatitis induced by nitrofurantoin. Gut 1994; 35: 712-3
41. Liviu L, Yair L, Yehuda S. Pancreatitis induced by clarithromycin. Ann Intern Med 1996; 125: 701
42. Schouwenberg BJ, Deinum J. Acute pancreatitis after a course of clarithromycin. Neth J Med 2003; 61: 266-7
43. Gonzalez Carro P, Perez Roldan F, Legaz Huidobro ML, et al. Acute pancreatitis and modified-release clarithromycin. Ann Pharmacother 2004; 38: 508-9
44. Trimble GX. Acute pancreatitis induced by erythromycin. Am J Med 1989; 87: 701
45. Hawksworth CR. Acute pancreatitis associated with infusion of erythromycin lactobionate [letter]. BMJ 1989; 298: 190
46. Gumaste VV. Erythromycin-induced pancreatitis [letter]. Am J Med 1989; 86: 725
47. Berger TM, Cook WJ, O'Marcaigh AS, et al. Acute pancreatitis in a 12-year-old girl after an erythromycin overdose. Pediatrics 1992; 90: 624-6
48. Fang CC, Wang HP, Lin JT. Erythromycin-induced acute pancreatitis. J Toxicol Clin Toxicol 1996; 34: 93-5
49. Tenenbein MS, Tenenbein M. Acute pancreatitis due to erythromycin overdose. Pediatr Emerg Care 2005; 21: 675-6
50. Chan KL, Chan HS, Lui SF, et al. Recurrent acute pancreatitis induced by isoniazid. Tuber Lung Dis 1994; 75: 383-5
51. Rabassa A, Trey G, Shukla U, et al. Isoniazid-induced pancreatitis. Ann Intern Med 1994; 121: 433-4
52. Stephenson I, Wiselka MJ, Qualie MJ. Acute pancreatitis induced by isoniazid in the treatment of tuberculosis. Am J Gastroenterol 2001; 96: 2271-2
53. Chow KM, Szeto CC, Leung CB, et al. Recurrent acute pancreatitis after isoniazid. Neth J Med 2004; 62: 172-4
54. Di Martino V, Ezenfis J, Benhamou Y, et al. Severe acute pancreatitis related to the use of nelfinavir in HIV infection: report of a case with positive rechallenge. AIDS 1999; 13: 1421-3
55. Soylu AR, Dokmeci G, Tezel A, et al. Lamivudine-induced acute pancreatitis in a patient with decompensated Hbv-related chronic liver disease [letter]. J Clin Gastroenterol 2004; 38: 134
56. Seidlin M, Lambert JS, Dolin R, et al. Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine. AIDS 1992; 6: 831-5
57. Maxson CJ, Greenfield SM, Turner JL. Acute pancreatitis as a common complication of 2́,3́-dideoxyinosine therapy in the acquired immunodeficiency syndrome. Am J Gastroenterol 1992; 87: 708-13
58. Eland IA, Rasch MC, Sturkenboom MJ, et al. Acute pancreatitis attributed to the use of interferon alfa-2b. Gastroenterology 2000; 119: 230-3
59. Tannir NM, Talpaz M, Ghazal H, et al. Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia. Leuk Lymphoma 2000; 39: 647-50
60. Cecchi E, Forte P, Cini E, et al. Pancreatitis induced by pegylated interferon alfa 2b in a patient affected by chronic hepatitis C. Emerg Med Aust 2004; 16: 473-5
61. Chaudhari S, Park J, Anand BS, et al. Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C. Dig Dis Sci 2004; 49: 1000-6
62. Tahan V, Tahan G, Dane F, et al. Acute pancreatitis attributed to the use of pegylated interferon in a patient with chronic hepatitis C. J Gastrointestin Liver Dis 2007; 16: 224-5
63. Ozdogan O, Tahan V, Cincin A, et al. Acute pancreatitis associated with the use of peginterferon. Pancreas 2007; 34: 485-7
64. Murphey SA. Josephs AS. Acute pancreatitis associated with pentamidine therapy. Arch Intern Med 1981; 141: 56-8
65. Murphy RL, Noskin GA, Ehrenpreis ED. Acute pancreatitis associated with aerosolized pentamidine. Am J Med 1990; 88 (Suppl. 5N): 53N-6N
66. Gasser RA, Magill AJ, Oster CN, et al. Pancreatitis induced by pentavalent antimonials agents during treatment of Leishmaniasis. Clin Infec Dis 1993; 16: 83-90
67. de Lalla F, Pellizzer G, Gradoni L, et al. Acute pancreatitis associated with the administration of meglumine antimoniate for the treatment of visceral leishmaniasis. Clin Infect Dis 1993; 16: 730-1
68. Youssef SS, Iskandar SB, Scruggs J, et al. Acute pancreatitis associated with omeprazole. Int J Clin Pharmacol Ther 2005; 43: 558-61
69. Kawanishi H, Rudolph E, Bull FE. Azathioprine-induced acute pancreatitis [letter]. N Engl J Med 1973; 289: 357
70. Paloyan D, Levin B, Simonowitz D. Azathioprine associated acute pancreatitis. Dig Dis 1977; 22: 839-46
71. Guillaume P, Grandjean E, Male RJ. Azathioprine associated acute pancreatitis in the course of chronic active hepatitis. Dig Dis Sci 1984; 29: 78-80
72. Cappell MS, Das KM. Rapid development of pancreatitis following reuse of 6-mercaptopurine. J Clin Gastroenterol 1989; 11: 679-81
73. Sachedina B, Saibil F, Choen LB, et al. Acute pancreatitis due to 5-aminosaliscylate. Ann Intern Med 1989; 110: 490-2
74. Deprez P. Descamps C. Fiasse R. Pancreatitis induced by 5-aminosalicylic acid. Lancet 1989; 2 (8660): 445-6
75. Erdkamp F, Houben M, Ackerman E, et al. Pancreatitis induced by mesalazine. Neth J Med 1992; 41: 71-2
76. Toubanakis C, Batziou E, Galanopoulos G, et al. Acute pancreatitis after long term therapy with mesalazine, and hyperamylasemia associated with azathioprine in a patient with ulceratitis tive colitis. Eur J Gastroenterol Hepatol 2003; 15: 933-4
77. Poldermans D, van Blankenstein M. Pancreatitis induced by disodium azodisalicylate. Am J Gastroenterol 1998; 83: 578-80
78. Suryapranata H, deVries H. Pancreatitis associated with sulfasalazine [letter]. BMJ 1986; 292: 732
79. Camfield PR. Pancreatitis due to valproic acid. Lancet 1979; i: 1198-9
80. Coulter DL, Allen RJ. Pancreatitis associated with valproic acid therapy for epilepsy [letter]. Ann Neurol 1980; 7: 92
81. Fecik SE, Stoner SC, Raphael J, et al. Recurrent acute pancreatitis associated with valproic acid use for mood stabilization. J Clin Psychopharmacol 1999; 19: 483-4
82. Koller EA, Cross JT, Doraiswamy PM, et al. Pancreatitis associated with atypical antipsychotics: from the Food and Drug Administration's MedWatch surveillance system and published reports. Pharmacotherapy 2003; 23: 1123-30
83. Bayard JM, Descamps OS, Evrard S, et al. Case report: acute pancreatitis induced by clozapine. Acta Gastroenterol Belg 2005; 68: 92-4
84. Wehmeier PM, Heiser P, Remschmidt H. Pancreatitis followed by pericardial effusion in an adolescent treated with clozapine. J Clin Psychopharmacol 2003; 23: 102-3
85. Garlipp P, Rosenthal O, Haltenhof H, et al. The development of a clinical syndrome of asymptomatic pancreatitis and eosinophilia after treatment with clozapine in schizophrenia: implications for clinical care, recognition and management. J Clin Psychopharmacol 2002; 16: 399-400
86. Cerulli TR. Clozapine-associated pancreatitis. Harv Rev Psychiatr 1999; 7: 61-3
87. Bergemann N, Ehrig C, Diebold K. Asymptomatic pancreatitis associated with clozapine. Pharmacopsychiatry 1999; 32: 78-80
88. Gatto EM, Castronuovo AP, Uribe Roca MC. Clozapine and pancreatitis [letter]. Clin Neuropharmacol 1998; 21: 203
89. Jubert P, Fernandez R, Ruiz A. Clozapine-related pancreatitis. Ann Int Med 1994; 121: 722-3
90. Martin A. Acute pancreatitis associated with clozapine use [letter]. Am J Psychiatry 1992; 149: 714
91. Banks S, Marks IN. Hyperlipemic pancreatitis and the pill. Postgrad Med J 1970; 46: 576-88
92. Davidoff F, Tishler S, Rosoff C. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. N Engl J Med 1973; 289: 552-5
93. Parker W. Estrogen-induced pancreatitis. Clin Pharm 1983; 2: 75-9
94. Castro MR, Nguyen TT, O'Brien T. Clomiphene-induced severe hypertriglyceridemia and pancreatitis. Mayo Clin Proc 1999; 74: 1125-8
95. Keskin M, Songur Y, Isler M. Clomiphene-induced acute pancreatitis without hypertriglyceridemia. Am J Med Sci 2007; 333: 194-6
96. Blake WE, Pitcher ME. Estrogen-related pancreatitis in the setting of normal plasma lipids [case report]. Menopause 2003; 10: 99-101
97. Alagozlu H, Cindoruk M, Unal S. Tamoxifen-induced severe hypertriglyceridemia and acute pancreatitis. Clin Drug Investig 2006; 26: 297-302
98. Lin HH, Hsu CH, Chao YC. Tamoxifen-induced severe acute pancreatitis [a case report]. Dig Dis Sci 2004; 49: 997-9
99. Artac M, Sari R, Altunbas H, et al. Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus and breast cancer. J Chemother 2002; 14: 309-11
100. Noguchi M, Taniya T, Tajiri K, et al. Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen. Br J Surg 1987; 74: 586-7
101. Collis BM, George PM. Severe hypertriglyceridemia and hypercholesterolemia associated with tamoxifen use. Clin Oncol 1998; 10: 270-1
102. Elisaf MS, Nakou K, Liamis G, et al. Tamoxifen-induced severe hypertriglyceridemia and pancreatitis. Ann Oncol 2000; 11: 1067-9
103. Taguchi M, Yokota M, Koyano H, et al. Acute pancreatitis and parotitis induced by methimazole in a patient with Graves' disease. Clin Endocrinol 1999; 51: 667-70
104. Marazuela M, Sanchez de Paco G, Jimenez I, et al. Acute pancreatitis, hepatic cholestasis, and erythema nodosum induced by carbimazole treatment for Graves' disease. Endocr J 2002; 49: 315-8
105. Izraeli S, Adamson PC, Blaney SM, et al. Acute pancreatitis after ifosfamide therapy. Cancer 1994; 74: 1627-8
106. Altman AJ, Dinndorf P, Quinn JJ. Acute pancreatitis in association with cytosine arabinoside therapy. Cancer 1982; 49: 1384-6
107. McBride CE, Yavorski RT, Moses FM, et al. Acute pancreatitis associated with continuous infusion cytarabine therapy: a case report. Cancer 1996; 77: 2588-91
108. McGrail LH, Sehn LH, Weiss RB, et al. Pancreatitis during therapy of acute myeloid leukemia: cytarabine related? Ann Oncol 1999; 10: 1373-6
109. Shaw MT, Barnes CC, Madden FJ, et al. L-asparaginase and pancreatitis [letter]. Lancet 1970; 2: 721
110. Weetman R, Baehner R. Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy. Cancer 1974; 34: 780-5
111. Jain R, Ramanan SV. Iatrogenic pancreatitis: a fatal complication in the induction therapy for acute lymphocytic leukemia [letter]. Arch Intern Med 1978; 138: 1726
112. McLean R, Martin S, Lam-Po-Tang PR. Fatal case of L-asparaginase induced pancreatitis. Lancet 1982; 2 (8312): 1401-2
113. Nguyen DL, Wilson DA, Engelman ED, et al. Serial sonograms to detect pancreatitis in children receiving L-asparaginase. South Med J 1987; 80: 1133-6
114. Alvarez OA, Zimmerman G. Pegasparaginase-induced pancreatitis. Med Pediatr Oncol 2000; 34: 200-5
115. Top PC, Tissing WJ, Kuiper JW, et al. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage. Pediatr Blood Cancer 2005; 44: 95-7
116. Knoderer HM, Robarge J. Flockhart DA. Predicting asparaginase-associated pancreatitis. Pediatr Blood Cancer 2007; 49: 634-9
117. Hastier P, Buckley MJM, Peten EP, et al. A new source of drug-induced acute pancreatitis: codeine. Am J Gastroenterol 2000; 95: 3295-8
118. Memon A. Pancreatitis and sulindac. Ann Intern Med 1982; 97: 139
119. Klein SM, Khan MA. Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac. J Rheumatol 1983; 10: 512-3
120. Zygmunt D. Acute pancreatitis with long term sulindac. West J Med 1986; 44: 461-2
121. Wargo KA, Geveden BN, McConnell VJ. Cannabinoid-induced pancreatitis: a case series. JOP 2007; 8: 579-83
122. Grant P, Gandhi P. A case of cannabis-induced pancreatitis. JOP 2004; 5: 41-3
123. Flynn WJ, Freeman PG, Wickholdt LG. Pancreatitis associated with isotretinoin induced hypertriglyceridemia [letter]. Ann Intern Med 1987; 107: 63
124. McCarter TL, Chen YK. Marked hyperlipidemia and pancreatitis associated with isotretinoin therapy. Am J Gastroenterol 1992; 12: 1855-7
125. Jamshidi M, Obermeyer RJ, Govindaraj S, et al. Acute pancreatitis secondary to isotretinoin-induced hyperlipidemia. J Okla State Med Assoc 2002; 95: 79-80
126. Kumar AN, Schwartz DE, Lim KG. Propofol-induced pancreatitis: recurrence of pancreatitis after rechallenge. Chest 1999; 115: 1198-9
127. Thomson S, Hendry W, McFarlane G, et al. Epidemiology and outcome of acute pancreatitis. Br J Surg 1987; 74: 398-401
128. Lankisch PG, Dröge M, Gottesleben F. Drug-induced acute pancreatitis: incidence and severity. Gut 1995; 37: 565-7
129. Werth B, Kuhn M, Hartmann K, et al. Drug-induced pancreatitis: experience of the Swiss Drug Adverse Effects Centre. Schweiz Med Wochenschr 1995; 125: 731-4
130. Eland IA, van Puijenbroek EP, Sturkenboom MJ, et al. Drug-associated acute pancreatitis: twenty-one years of spontaneous reporting in the Netherlands. Am J Gastroenterol 1999; 94: 2417-22
131. Andersen V, Sonne J, Andersen M. Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999. Eur J Clin Pharmacol 2001; 57: 517-21
132. Dutta SK, Ting CD, Lai LL. Study of prevalence, severity, and etiological factors associated with acute pancreatitis in patients infected with human immunodeficiency virus. Am J Gastroenterol 1997; 92: 2044-8
133. Munk EM, Pedersen L, Floyd A, et al. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study. Am J Gastroenterol 2004; 99: 884-8
134. Banerjee AK, Patel KJ, Grainger SL. Drug-induced pancreatitis: a critical review. Med Toxicol Adverse Drug Exp 1989; 4: 186-98
135. Tilkemeier P, Thompson P. Acute pancreatitis possibly related to enalapril. N Engl J Med 1988; 318: 275-6
136. Martin T, Taupignon A, Graf E, et al. Pancreatitis and hepatitis in a patient treated with enalapril maleate: a case report. Therapie 1989; 44: 449-50
137. Gonzalez Ramallo VJ, Muino Miguez A, Torres Segovia FJ. Necrotizing pancreatitis and enalapril [letter]. Eur J Med 1992; 1: 123
138. Jeandidier N, Klewansky M, Pinget M. Captopril-induced acute pancreatitis. Diabetes Care 1995; 18: 410-1
139. Iliopoulou A, Giannakopoulous G, Pagoy H, et al. Acute pancreatitis due to captopril treatment. Dig Dis Sci 2001; 46: 1882-3
140. Maliekal J, Drake CF. Acute pancreatitis associated with the use of lisinopril. Ann Pharmacother 1993; 27: 1465-6
141. Standridge JB. Fulminant pancreatitis associated with lisinopril therapy. South Med J 1994; 87: 179-81
142. Marinella MA, Billi JE. Lisinopril therapy associated with acute pancreatitis. West J Med 1995; 163: 77-8
143. Kanbay M, Sekuk H, Yilmaz U, et al. Acute pancreatitis associated with combined lisinopril and atorvastatin therapy. Dig Dis 2005; 23: 92-4
144. Arjomand H, Kemp DG. Quinapril and pancreatitis. Am J Gastroenterol 1999; 94: 290-1
145. Anagnostopoulos GK, Kostopoulos P, Tsiakos S, et al. Fulminant pancreatitis associated with ramipril therapy. Pancreas 2003; 27: 278-9
146. Gallego-Rojo FJ, Gonzalez-Calvin JL, Guilarte J, et al. Per-indopril-induced acute pancreatitis. Dig Dis Sci 1997; 42: 1789-91
147. Eland IA, Sundstrom A, Velo GP, et al. Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis. Scand J Gastroenterol 2006; 41: 1484-90
148. Baffoni L, Durante V, Grossi M. Acute pancreatitis induced by telmisartan overdose [letter]. Ann Pharmacother 2004; 38: 1088
149. Cjaka C, Buclin T, Brunner HR, et al. Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonist. Clin Pharmacokinet 1997; 1: 1-29
150. Leung PS. Local rennin-angiotensin system in the pancreas. JOP J Pancreas (Online) 2001; 2: 3-8 [online]. Available from URL: www.joplink.net [Accessed 2008 Aug 25]
151. McDonald KB, Garber BG, Perreault MM. Pancreatitis associated with simvastatin plus fenofibrate. Ann Pharmacother 2002; 36: 275-9
152. Antonopoulos S, Mikros S, Kokkoris S, et al. A case of acute pancreatitis possibly associated with combined salicylate and simvastatin treatment. JOP 2005; 6: 264-8
153. Miltiadous G, Anthopoulou A, Elisaf M. Acute pancreatitis possibly associated with combined salicylate and atorvastatin. therapy. JOP 2003; 4: 20-1
154. Kanbay M, Sekuk H, Yilmaz U, et al. Acute pancreatitis associated with combined lisinopril and atorvastatin therapy. Dig Dis 2005; 23: 92-4
155. Singh S, Nautiyal A, Dolan JG. Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin: is statin induced pancreatitis a class effect? JOP 2004; 5: 502-4
156. Wong PW, Dillard TA, Kroenke K. Multiple organ toxicity from addition of erythromycin to long-term lovastatin therapy. South Med J 1998; 91: 202-5
157. Abdul-Ghaffar NU, el-Sonbaty MR. Pancreatitis and rhabdomyolysis associated with lovastatin-gemfibrozil therapy. J Clin Gastroenterol 1995; 21: 340-1
158. Tsigrelis C, Pitchumoni CS. Pravastatin: a potential cause for acute pancreatitis. World J Gastroenterol 2006; 12: 7055-7
159. Singh S, Loke YK. Statins and pancreatitis: a systematic review of observational studies and spontaneous case reports. Drug Saf 2006; 29: 1123-32
160. Thisted H, Jacobsen J, Munk EM, et al. Statins and the risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther 2006; 23: 185-90
161. Ober WB, LeCompte PM. Acute fatty metamorphosis of the liver associated with pregnancy. Am J Med 1955; 19: 743-58
162. Schultz J, Adamson J, Workman W, et al. Fatal liver disease after intravenous administration of tetracycline in high dosage. N Engl J Med 1963; 269: 999-1004
163. Whalley PJ, Adams RH, Combes B. Tetracycline toxicity in pregnancy: liver and pancreatic dysfunction. JAMA 1964; 189: 103-8
164. Kunelis CT, Peters JL, Edmondson HA. Fatty liver of pregnancy and its relationship to tetracycline therapy. Am J Med 1965; 38: 359-77
165. Peters R, Edmondson H, Mikkelsen WP, et al. Tetracycline induced fatty liver in non-pregnant patients: a report of six cases. Am J Surg 1967; 113: 622-32
166. Nicolau DP, Mengedoht DE, Kline JJ. Tetracycline induced pancreatitis. Am J Gastroenterol 1991; 86: 1669-71
167. Steinberg WM. Acute drug and toxin induced pancreatitis. Hosp Pract 1985; 20: 95-102
168. Plotnick BH, Cohen I, Tsang T, et al. Metronidazole-induced pancreatitis. Ann Intern Med 1985; 103: 891-2
169. Corey WA, Doebbeling BN, DeJong KJ, et al. Metronidazole-induced acute pancreatitis. Rev Infect Dis 1991; 13: 1213-5
170. Sura ME, Heinrich KA, Suseno M. Metronidazole-associated pancreatitis. Ann Pharmacother 2000; 34: 1152-5
171. Feola DJ, Thornton AC. Metronidazole-induced pancreatitis in a patient with recurrent vaginal trichomoniasis. Pharmacotherapy 2002; 22: 1508-10
172. Nigwekar SU, Casey KJ. Metronidazole induced pancreatitis: a case report and review of the literature. JOP 2004; 5: 516-9
173. Tsesmeli NE. Giannoulis KE. Savopoulos CG, et al. Acute pancreatitis as a possible consequence of metronidazole during a relapse of ulcerative colitis. Eur J Gastroenterol Hepatol 2007; 19: 805-6
174. Friedman GD, Selby JV. How often does metronidazole induce pancreatitis? Gastroenterology 1990; 98: 1702-3
175. Wallace JR, Cushing RD, Bawdon RE, et al. Assessment of antimicrobial penetrance into the pancreatic juice in humans. Surg Gynecol Obstet 1986; 162: 313-6
176. Kvale PA, Parks RD. Acute abdomen: an usual reaction to isoniazid. Chest 1975; 68: 271-2
177. Mendoza JL, Lana R, Espinos D, et al. Acute pancreatitis induced by isoniazid, a causal association. Ann Med Interne (Paris) 1998; 15: 588-90
178. Izzedine H, Launay-Vachar V, Stomme T, et al. Acute pancreatitis induced by isoniazid. Am J Gastroenterol 2001; 96: 3208-9
179. Jin CF, Sabie R. Isoniazid-induced acute hepatitis and acute pancreatitis in a patient during chemoprophylaxis. J Clin Gastroenterol 2002; 35: 100-1
180. Chan TY. Isoniazid and rifampicin rarely cause acute pancreatitis in patients with tuberculosis [letter]. Int J Clin Pharmacol Ther 1999; 37: 109
181. Mattson K. Side effects of rifampicin: a clinical study. Scand J Respir Dis 1973; 82 Suppl.: 8-52
182. Broeckaert van Orshoven A, Michielsen P, Vandepitte J. Fatal leishmaniasis in a renal transplant recipient. Lancet 1979; ii: 740-1
183. McCarthy A, Keystone J, Kain K. Pancreatitis occurring during therapy with stibogluconate: two case reports. Clin Infect Dis 1993; 17: 952-3
184. Laguna F, Soriano V, Gonzalez-Labor J. Misdiagnosis in patients receiving treatment with pentavalent antimonial patients. Clin Infect Dis 1994; 19: 978-9
185. Aronson NE, Wortmann GW, Johnson SC, et al. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent US military experience. Clin Infect Dis 1998; 27: 1457-64
186. Wortmann G, Miller SR, Oster C. a randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel. Clin Infect Dis 2002; 35: 261-7
187. McBride MO, Linney M, Davidson RN, et al. Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconate [letter]. Clin Infect Dis 1995; 21: 710
188. Delgado J, Macias J, Pineda JA, et al. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodificiency virus type-1 infected patients. Am J Trop Med Hyg 1999; 61: 766-9
189. Brundtland GH. World Health Organization Report on Infectious Diseases 2000. Overcoming antimicrobial resistance [online]. Available from URL: http://www.who.int/infectious-disease-report/2000/ [Accessed 2008 Aug 25]
190. Johnson WC, Nasbeth DC. Pancreatitis in renal transplantation. Ann Surg 1970; 171: 309-14
191. Nogueira JR, Freedman MA. Acute pancreatitis as a complication of imuran therapy in regional enteritis. Gastroenterology 1972; 62: 1040-1
192. Sturdevant RAL, Singleton JW, Deren JJ, et al. Azathioprine-related pancreatitis in patients with Crohn's disease. Gastroenterology 1979; 77: 883-6
193. Bank L, Wright JP. 6-Mercaptopurine-related pancreatitis in 2 patients with inflammatory bowel disease. Dig Dis Sci 1984; 29: 357-9
194. Haber CJ, Meltzer SJ, Present DH, et al. Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease. Gastroenterology 1986; 91: 982-6
195. Present DH, Meltzer SJ, Krumholz MP, et al. 6-Mercaptopurine in the management of inflammatory bowel disease: short and long-term toxicity. Ann Intern Med 1989; 111: 641-9
196. Floyd A, Pedersen L, Nielsen GL, et al. Risk of acute pancreatitis in users of azathioprine: a population-based case-control study. Am J Gastroenterol 2003; 98: 1305-8
197. Block MB, Genant HK, Kirsner JB. Pancreatitis as an adverse reaction to salicylazosulfapuridine. N Engl J Med 1970; 282: 380-2
198. Faintuch J, Mott C, Machado M. Pancreatitis and pancreatic necrosis during sulfasalazine therapy. Int Surg 1985; 70: 271-2
199. Rubin R. Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis. Am J Gastroenterol 1994; 89: 789-91
200. Garau P, Orenstein S, Neigut D, et al. Pancreatitis associated with olsalazine and sulfasalazine in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 1994; 18: 481-5
201. Isaacs KL, Murphy D. Pancreatitis after rectal administration of 5-aminosalicylic acid. J Clin Gastroenterol 1990; 12: 198-9
202. Fernandez J, Sala M, Panes J, et al. Acute pancreatitis after long term 5-aminosalicylic acid therapy. Am J Gastroenterol 1997; 92: 2302-3
203. Ransford RA, Langman MJ. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut 2002; 51: 536-9
204. Fiorentini MT, Fracchia M, Galatola G, et al. Acute pancreatitis during oral 5-aminosalicylic acid therapy. Dig Dis Sci 1990; 35 (9): 1180-2
205. Debongnie J, Dekoninck X. Sulfasalazine, 5-ASA, and acute pancreatitis in Crohn's disease. J Clin Gastroenterol 1994; 19: 348-9
206. Butalden PB, Van Dyne BJ, Cloyd J. Pancreatitis associated with valproic acid therapy. Pediatrics 1979; 64: 520-2
207. Buzan RD, Firestone D, Thomas M, et al. Valproate-associated pancreatitis and cholecystitis in six mentally retarded adults. J Clin Psychiatry 1995; 56: 529-32
208. Parker PH, Helinek GL, Ghishan FK, et al. Recurrent pancreatitis induced by valproic acid. Gastroenterology 1981; 80: 826-8
209. Williams LH, Reynolds RP, Emery JL. Pancreatitis during sodium valproate treatment. Arch Dis Child 1983; 58: 543-4
210. Wyllie E, Wyllie R, Cruse RP, et al. Pancreatitis associated with valproic acid therapy. Am J Dis Child 1984; 138: 912-4
211. Baskies AM. Pancreatic pseudocyst associated with valproic acid therapy. J Med Soc N J 1984; 81: 399-400
212. Ford DM, Portman RJ, Lum GM. Pancreatitis in children on chronic dialysis treated with valproic acid. Pediatr Nephrol 1990; 4: 259-61
213. Evans RJ, Miranda RN, Jordan J. Fatal acute pancreatitis caused by valproic acid. Am J Forensic Med Pathol 1995; 16: 62-5
214. Lott JA, Bond LW, Bobo RC, et al. Valproic acid-associated pancreatitis: report of three cases and a brief review. Clin Chem 1990; 36: 395-7
215. Sinclair DB, Berg M, Breault R. Valproic acid-induced pancreatitis in childhood epilepsy: case series and review. J Child Neurol 2004; 19: 498-02
216. Werlin SL, Kugathasa S, Frautschy BC. Pancreatitis in children. J Pediatr Gastroenterol Nutr 2003; 37: 591-5
217. Zorilla E, Hulse M, Hernandez A, et al. Severe endogenous hypertriglyceridemia during treatment with estrogen and oral contraceptives. J Clin Endocrinol Metab 1968; 28: 1793-6
218. Glueck CJ, Scheel D, Fishback J, et al. Estrogen-induced pancreatitis in patients with previously covert familial type 5 hyperlipoproteinemia. Metabolism 1972; 21: 657-66
219. Anon. Pancreatitis from oral contraceptives [editorial]. BMJ 1973; 4: 688-9
220. Molitich ME, Oill P, Odell WD. Massive hyperlipemia during estrogen therapy. JAMA 1974; 227: 522-5
221. Foster ME, Powell DEB. Pancreatitis, multiple infarcts, and oral contraception. Postgrad Med J 1975; 51: 667-9
222. Mungall IP, Hague RV. Pancreatitis and the pill. Postgrad Med J 1975; 51: 855-7
223. Glueck CJ, Scheel D, Fishback J, et al. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. J Lab Clin Med 1994; 123: 59-64
224. Ruman J, Brenner S, Sauer MV. Severe hypertriglyceridemia and pancreatitis following hormone replacement prior to cryothaw transfer. J Assist Reprod Genet 2002; 19: 94-7
225. Perego E, Scaini A, Romano F, et al. Estrogen-induced severe acute pancreatitis in a male. JOP J Pancreas (Online) 2004; 5 (5): 353-6 [online]. Available from URL: www.joplink.net [Accessed 2008 Aug 25]
226. Stuyt PM, Demacker PN, Stalenhoef AF. Pancreatitis induced by oestrogen in a patient with type I hyperlipoproteinemia [letter]. BMJ (Clin Res Ed) 1986; 293: 734
227. Wallace RB, Hoover J, Sandler D, et al. Altered plasma lipids associated with oral contraceptive or estrogen consumption. Lancet 1977; 2: 11-4
228. Stokes T, Wynn V. Serum lipids in women on oral contraceptives. Lancet 1971; 2: 677-80
229. Lankisch PG, Niederstadt H, Redlin-Kress E, et al. Acute pancreatitis: induced by heroin intoxication? Pancreas 1993; 8: 123-6
230. Beamish N, Schwarer P, Watson AM. Acute pancreatitis complicating a bone marrow harvest. Bone Marrow Transplant 1997; 19: 525-6
231. Moreno Escobosa MC, Amat Lopez J, Cruz Granados S, et al. Pancreatitis due to codeine. Allergol Immunopathol 2005; 33: 175-7
232. Steinberg WM, Toskes PP, Salvato RF. Non-specificity of the morphine-prostigmine test [abstract]. Gastroenterology 1979; 76: A1255
233. Roberts-Thompson IC, Toouli J. Abnormal responses to morphine-neostigmine in patients with undefined biliary-type pain. Gut 1985; 26: 1367-72
234. Gross JB, Comfort MW, Mathieson DR, et al. Elevated values for serum enzymes and lipase following the administration of opiates: a preliminary report. Proc Mayo Clinic 1951; 26: 81-7
235. Goldstein J, Laskin DA, Ginsberg GH. Sulindac associated pancreatitis. Ann Intern Med 1980; 93: 151
236. Siefkin AD. Sulindac and pancreatitis. Ann Intern Med 1980; 93: 932-3
237. Lilly EL. Pancreatitis after administration of sulindac [letter]. JAMA 1981; 246: 2680
238. Lerche A. Vyberg, M. Kirkegaard, E. Acute cholangitis and pancreatitis associated with sulindac (clinoril). Histopathology 1987; 11: 647-53
239. Sugarman HJ. Sulindac-induced acute pancreatitis mimicking gallstone pancreatitis. Am Surg 1989; 55: 536-8